Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease under MedlinePlus Genetics, and Fatty Liver Disease as related topics. The update appears in the related topics section and does not modify core trial details, eligibility, or results.SummaryDifference0.6%

- Check20 days agoChange Detected- Deleted page metadata terms: 'Non-alcoholic fatty liver disease' and the related topics tag 'MedlinePlus Genetics' from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedCore page content updated with a government-operating-status notice and a new MedlinePlus Genetics topic; page version bumped from v3.1.0 to v3.2.0.SummaryDifference6%

- Check49 days agoChange DetectedUpdate to version v3.1.0; removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and a MedlinePlus Genetics topic) indicating content pruning alongside the core revision.SummaryDifference1%

- Check56 days agoChange Detected- Added MedlinePlus Genetics topic: Non-alcoholic fatty liver disease. - No deletions observed.SummaryDifference0.5%

- Check63 days agoChange DetectedThe page updates from Revision: v3.0.1 to v3.0.2, signaling a new release. Additionally, the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.3%

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.